Member Info for whitto

11:54:36 2.43 1,678,571 40.79k sell showing

ahhhhhhhh . now i get it . many thanks .

chesh .. pls can u explain to me why all these tiny trades showing up .. is it a glitch . thanks

Mobile Streams plc, the AIM quoted mobile content and data intelligence company, is pleased to provide a trading update following the year ended 30 June 2020.



The year to 30 June 2020 saw significant change for your Company, with a new Board and Senior Management team, new advisers, placings in November, April and May, and the launch of the Streams data intelligence business. The Company has progressed from a state of near collapse with plans to de-list last September to being well funded and with clear, positive growth plans driven by its new leadership team.



Trading results to 30 June 2020



Content Business

Unaudited management accounts show that revenues from the legacy mobile content business declined from £1,335k in 2019 to approximately £470k, with net revenues after payments to carriers declining from £501k to approximately £110k. Despite these expected results, largely due to lack of investment in previous years, the Company retains long established relationships with several leading carriers and is reviewing whether to make additional investment in the content business. The Company made significant cuts to its cost base and therefore, despite the significant drop in both revenues and contribution from the content business, it expects to report an overall EBITDA loss for the existing business (ie after all Group costs other than those of the Data Business as described below) similar to the £666k reported for 2019.



Data Business

As previously announced, the Company's 'Streams' platform and services were launched in April, with the first commercial agreement signed with the National Emergencies Trust ("NET") in April, and two further clients (Orckid, a digital product and brand development agency within the Selbey Anderson Group and the Education division of The Economist Group) signed in June. Given the timing of the launch, Streams revenues in the year to 30 June only included those generated by the NET contract in that month, and represented roughly 2% of the Group's £480k 2020 revenue. Encouragingly, in June 2020 whilst Content Business revenue remained stable, revenues from the Data Business represented 20% of gross Group revenue. Revenues from the Data Business are expected to grow significantly in the current year.



In July the Company launched the Streams SaaS ("Software as a Service") insight platform (the "SaaS Platform") to enable customers to sign up for a customer driven, digital marketing tool providing many of the features available under the Company's existing Streams platform. The Company has signed up over 30 initial customers for the SaaS Platform, who will typically receive their first month free and it is hoped that many will then will convert to monthly subscriptions.



The Company aims to release its full audited report and accounts for the year to 30 June in October 2020.

Final results for the year ended 31 December 2019

Velocys plc (VLS.L), the sustainable fuels technology company, is pleased to announce its final audited results for the year ended 31 December 2019.



Highlights

· Fund raise of £7m (before expenses) in July 2019 and an additional fund raise of £21m (before expenses) in July 2020.

· Altalto Immingham Project strategic partners, British Airways and Shell, commitment of £2.8 million in July 2019.

· Revenue of £0.3m (2018: £0.7m).

· Operating loss of £9.6m, before exceptional items including a credit of £0.1m related to impairments (2018: loss of £18.6m before exceptional items of £10.1m).

· Administrative expenses before exceptional items reduced significantly to £9.9m (£9.8m after exceptional items) compared to 2018 £19.1m (£29.1m after exceptional items).

· Loss before income tax of £10.0m before exceptional items including a credit of £0.1m related to impairments (2018: loss of £20.0m before exceptional items of £10.9m).

· Cash at period end £4.8m (31 December 2018: £7.0m).

· Amended Red Rock Biofuels licensing contract in February 2019 with delivery of the first reactor in Q4 2019 and completion of delivery of the other 3 reactors in H1 2020.

· Planning application for a commercial waste to fuel plant submitted to North East Lincolnshire County Council for the Altalto Immingham project.

· Contracted, manufactured and now delivered Fischer-Tropsch (FT) reactors and catalyst to Toyo Engineering Corporation (Toyo) for use in a biomass-to-jet fuel demonstration facility in Nagoya, Japan.

· Bayou Fuels project set to produce negative emission fuels after signing Carbon Capture Utilisation and Storage (CCUS) agreement with Oxy Low Carbon Ventures.

· Appointed Worley (EPC) to manage delivery of our technology globally.

· Licensors on-board include: TRI, Arvos, Air Liquide, Linde and Haldor Topsoe A/S.

· Velocys classified as a Green Economy Issuer by the London Stock Exchange.

g/t g/t % % %
Drill Hole ID Depth (m) From (m) To (m) Length (m) Lithology Au Ag Cu Pb Zn
BP18_004 35.1 10.5 15 4.5 Skarn 0.04 12.54 0.20 0.10 0.12
BP18_005 37.5 21.5 31 9.5 Skarn 2.36 210.64 4.04 0.13 0.56
including 21.5 26 4.5 Skarn 4.56 389.89 7.69 0.11 0.33
BP18_006 30 11 16 5 Skarn + Limestone 1.74 180.00 2.78 0.77 2.18
including 11 13 2 Skarn 2.73 188.00 5.32 0.56 0.17
BP18_007 20 9 13 4 Skarn 0.15 19.80 0.82 0.07 0.05
BP18_008 18 6 13 7 Skarn 0.82 57.54 1.35 0.31 0.08
BP18_009 26.5 11 19.5 8.5 Skarn 0.45 59.19 0.98 0.19 0.05
BP18_010 30 7 10 3 Skarn 0.19 15.07 0.34 0.02 0.03
14 19 5 Skarn 1.18 106.42 1.74 0.09 0.02
21 22 1 Skarn 0.11 236.00 0.02 1.12 1.86
BP18_011 39 28 36 8 Skarn 0.38 27.89 1.19 0.22 0.04
BP18_012 34.5 15 18 3 Skarn 0.34 31.93 0.50 0.08 0.02
18 22 4 Skarn 0.20 231.00 0.19 1.69 1.38
28 29 1 Skarn + Limestone 0.01 112.00 0.01 0.45 0.02
BP18_013 60 35 48 13 Skarn 0.22 68.91 1.05 0.32 0.13
51 55 4 Skarn 0.01 78.23 0.05 0.36 0.09
BP18_014 45.8 21 36 15 Skarn 1.09 103.09 1.45 0.39 0.07
including 30 35 5 Skarn 2.89 137.44 2.80 0.02 0.04
BP18_016 42.7 25 31 6 Skarn + Fault 0.06 13.03 0.40 0.03 0.02
BP18_017 27.8 11 20 9 Skarn + Breccia 1.34 66.82 3.36 0.87 1.38
including 12 16 4 Skarn 2.76 116.05 7.27 1.79 2.68
BP18_018 27.6 14 18.5 4.5 Skarn + Limestone 1.61 97.62 1.79 0.04 0.02
BP18_019 36.4 5 10 5 Skarn + Limestone 2.87 162.08 4.67 0.01 0.02
including 5 6 1 Skarn 6.48 438.00 11.55 0.03 0.09
including 8.4 10 1.6 Skarn 7.88 372.38 11.78 0.02 0.03
18 24 6 Skarn + Limestone 0.20 23.67 0.71 0.02 0.02
27.5 29 1.5 Skarn + Limestone 0.52 49.80 3.17 0.03 0.13
34 35 1 Skarn + Limestone 0.76 29.10 0.43 0.00 0.00

in may it was 41p .. this will be smashed soon imo

im with u casp . just moved some cash out of other shares and bought more at avg 19p . this will rocket upon news

our holding in RMS to be a Strategic Investment and therefore, as at the date of this report, now hold investments in seven Strategic Investments (including Paraytec, Kirkstall and Pharm 2 Farm) as follows:

· Phasefocus Holdings Limited;

· Paraytec Limited;

· Sentinel Medical Limited;

· Kirkstall Limited;

· Gyrometric Systems Limited;

· Pharm2Farm Limited; and

· Remote Monitored Systems plc. THIS TODAY IS 3P PER FOR EACH INTEREST AND I THINK A FEW COULD MULTI BAG .. MAKES THIS SHARE A NO BAINER GLA

50
Vol. Sold 144,168
Sold Value £3,388
Vol. Bought 2,387,937
Bought Value £56.12k
PE Ratio -2.374
Earnings -0.99
Dividend 0.00
Yield 0.00%

hope so . value 1.6 billion .. offer £2.50 per share hstg

enzyme-catalysed production of DNA corresponding to known viral genes, a process that takes several hours, and requires access to highly specialised lab equipment. Other approaches have begun to be rolled out (see https://www.gov.uk/government/news/roll-out-of-2-new-rapid-coronavirus-tests-ahead-of-winter). These, while avoiding specialised equipment, nonetheless also target viral genes, generating a positive signal via an enzyme-catalysed reaction, which takes 1.5 hours. This of necessity reduces the number of tests that can be performed in any one day. Our approach, in which viral attachment to affinity macromolecules may be imaged directly using a highly sensitive detection system, has the potential both to undertake many tests in parallel, as well as delivering results in minutes, all without the need for trained health professionals for their operation.

Braveheart Investment Group plc

("Braveheart" or the "Group")

Further re Paraytec Limited

Further to the announcement made on 7 July 2020, Braveheart is pleased to provide an update concerning the development of a COVID-19 test that Paraytec Limited is conducting with the University of Sheffield.

WP1 Construction of a viral mimic

Braveheart previously reported on the successful production of the viral SPIKE protein. It can now report that sub-micron-sized polystyrene microspheres have been produced to which multiple copies of the SPIKE protein have been successfully bonded, generating a viral mimic that is the same size as the COVID-19 coronavirus, thus completing this workpackage.

WP2 Development of CAPTURE system



The CAPTURE module comprises a system in which a specialised surface is coated with a macromolecule that binds the virus very tightly. Here the virus-binding molecule undergoing analysis is COVID-19 DNA aptamer that has been supplied to Paraytec. The biotin-binding protein avidin has been bonded to the Capture module, which is composed of 10 micron microspheres, and the resultant surface coated with a biotinylated derivative of the aptamer, completing this workpackage.



WP3 Development of the Signal Generation Module



Construction of Signal Generation components has begun. The Signal Generation module consists of fluorescent-nanospheres derivatised with a synthetic COVID-19 virus binding protein that associates with trapped virus particles within 5 minutes. The DNA coding for the synthetic protein has been generated and has been introduced into cells growing in culture, to enable the protein to be purified and subsequently coated onto the nanospheres. Purified protein has been obtained and work has been initiated to ensure the protein will be correctly oriented when attached to nanospheres, to maximise the rate of association with viral particles, and thus the speed at which a test result can be generated.



Over the next month, it is expected that the construction of the Signal Generation module will be completed, which will lead the way to establishing proof-of-concept by early October.



Professor Carl Smythe commented "We continue to make progress in the development of this novel approach to testing for Coronavirus. A key requirement is the ability to deliver a test result with very fast turnaround. The current gold standard uses PCR which involves repeated rounds of enzyme-catalysed production of DNA corresponding to known viral genes, a process that takes several hours, and requires access to highly specialised lab equipment. Other approaches have begun to be rolled out (see https://www.gov.uk/government/news/roll-out-of-2-new-rapid-coronavirus-tests-ahead-of-winter). These, while avoiding specialised equipment, nonetheless also target viral genes, generating a positive signal via an enzyme-catalysed reaction, which takes 1.5 hours. This of necessity reduces the number o

11:08:37 6.40 300,000 19.20k

12:27:08 17.2001 500,000 86.00k SELL

kop . im just the messenger . do ure own research . there are charts showing why pepes come out with this projected valuation . personally anything above £1 and im a very happy bunny .gla

postings on twitter getting lots of attention ...#EUA its becoming clear that this is going to be one of the deals of the decade on AIM.

£2.21 looks nailed on but that's without multiple bids......

03-Aug-20 16:22:51 17.00 1,904,225 Sell* 17.00 18.00 323.72k

all buys showing as sells

a must read . superb company imo